Search Results - "Zhu, Linrong"

Solid Form Selection and Process Development of KO-947 Drug Substances by Mei, Bo, Zhu, Linrong, Guo, Yushen, Wu, Tao, Ren, Pingda, Deng, Xiaohu

“…KO-947 is a potent, selective extracellular signal-regulated kinases (ERK) inhibitor that was investigated in the clinic for the treatment of various solid…”
Get full text

Design, Synthesis, and Characterization of I‑BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate by Humphreys, Philip G, Atkinson, Stephen J, Bamborough, Paul, Bit, Rino A, Chung, Chun-wa, Craggs, Peter D, Cutler, Leanne, Davis, Rob, Ferrie, Alan, Gong, GangLi, Gordon, Laurie J, Gray, Matthew, Harrison, Lee A, Hayhow, Thomas G, Haynes, Andrea, Henley, Nick, Hirst, David J, Holyer, Ian D, Lindon, Matthew J, Lovatt, Cerys, Lugo, David, McCleary, Scott, Molnar, Judit, Osmani, Qendresa, Patten, Chris, Preston, Alex, Rioja, Inmaculada, Seal, Jonathan T, Smithers, Nicholas, Sun, Fenglai, Tang, Dalin, Taylor, Simon, Theodoulou, Natalie H, Thomas, Clare, Watson, Robert J, Wellaway, Christopher R, Zhu, Linrong, Tomkinson, Nicholas C. O, Prinjha, Rab K

“…Through regulation of the epigenome, the bromodomain and extra terminal (BET) family of proteins represent important therapeutic targets for the treatment of…”
Get full text

Design and Synthesis of 4-(2,4,5-Trifluorophenyl)butane-1,3-diamines as Dipeptidyl Peptidase IV Inhibitors by Zhu, Linrong, Li, Yuanyuan, Qiu, Ling, Su, Mingbo, Wang, Xin, Xia, Chunmei, Qu, Yi, Li, Jingya, Li, Jia, Xiong, Bing, Shen, Jingkang

“…The worldwide prevalence of diabetes has spurred numerous studies on the development of new antidiabetic medicines. As a result, dipeptidyl peptidase IV (DPP4)…”
Get full text

Design and Synthesis of 4-(2,4,5-Trifluorophenyl)butane-1,3-diamines as Dipeptidyl PeptidaseIV Inhibitors by Zhu, Linrong, Li, Yuanyuan, Qiu, Ling, Su, Mingbo, Wang, Xin, Xia, Chunmei, Qu, Yi, Li, Jingya, Li, Jia, Xiong, Bing, Shen, Jingkang

“…The worldwide prevalence of diabetes has spurred numerous studies on the development of new antidiabetic medicines. As a result, dipeptidyl peptidaseIV (DPP4)…”
Get full text